2019 Speakers

 

Stewart Abbot, Chief Scientific Officer, Adicet Bio

Karen S Aboody, Professor, City of Hope Comprehensive Cancer Center

Nabil Al Humadi, Pharmacologist And Toxicologist, Food and Drug Administration (FDA)

Dr M Javad Aman, Chief Executive Officer, Integrated Biotherapeutics

Bruno Anspach, Director Of Clinical Operations Latin America - Vaccines, GlaxoSmithKline

Eric Appel, Assistant Professor of Material Science and Engineering, Stanford University

Sina Bavari, Chief Of Molecular And Translational Sciences, U.S. Army Medical Research Institute of Infectious Diseases

Sean Bennett, Senior Director Of Clinical Development and Medical Affairs, Emergent BioSolutions

Praveen Bommareddy, Transnational Research Lead, Replimune

Catharine Mans Bosio, Senior Investigator, NIAID-NIH

Maureen Bruhns, Senior Director, Analytical Development, Sutro Biopharma

David Canton, Director, R&D And Clinical Science, OncoSec Medical

Darrick Carter, Vice President - Adjuvant Technology, I.D.R.I.

Grace Chen, Deputy Chief Of The Clinical Trials Program In The Vrc, National Institutes of Health

Trevor Clancy, Chief Scientific Officer, NEC OncoImmunity AS

Dr Chris Clegg, President, Founder and Chief Scientific Officer, TRIA Bioscience

Dr Chris Clegg | President, Founder and Chief Scientific Officer | TRIA Bioscience » speaking at Vaccine West Coast

Dr Rachel Clemens, Commercial Innovation Manager, Center for the Advancement of Science In Space

Dr Ezra Cohen, Associate Director Of Moores Cancer Center, U.C. San Diego Moores Cancer Center

Jason E Comer, Assistant Professor, Department Microbiology And Immunology, University of Texas Medical Branch

Timothy Cooke, Chief Executive Officer, NovaDigm Therapeutics

Dr Rajeev Dadoo, Partner, S.R. One

Adil Daud, Professor of Hematology, Oncology and Director, U.C.S.F. Helen Diller Family Comprehensive Cancer Center

Patrick Daugherty, CSO and Founder, SerImmune

Mark M Davis, Professor, Microbiology & Immunology, Director, Stanford Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine

Tom Davis, Chief Medical Officer, Genocea Biosciences

Victor Defilippis, Associate Professor, Oregon Health and Science

Victor Defilippis | Associate Professor | Oregon Health and Science » speaking at Vaccine West Coast

Daryl Drummond, Biotechnology Consultant

Daryl Drummond |  | Biotechnology Consultant » speaking at Vaccine West Coast

Erin Duffy, Chief of Research and Development, CARB-X

Dr Roland Dunbrack, Professor, Fox Chase Cancer Center

Leonard Friedland, Vice President, Scientific Affairs And Public Health Vaccines, North America, GSK

Dr Jeffrey Froude, Major, Stm, Vaccines And Therapeutics Division, Defense Threat Reduction Agency

Dr Evanthia Galanis, Professor, Chair Molecular Medicine, Mayo Clinic

Pamela Garzone, Chief Medical Officer, Calibr, a division of Scripps Research

Dr Hanspeter Gerber, Senior Vice President and Chief Scientific Officer, 3T Biosciences

Aubree Gordon, Associate Professor Of Epidemiology, University of Michigan School of Public Health

Farshad Guirakhoo, Chief Scientific Officer, GeoVax, Inc.

Willem Hanekom, Deputy Director, Tb Vaccines,, Bill & Melinda Gates Foundation

Ali M. Harandi, Lab head, Dpt of Microbiology & Immunology, University of Gothenburg

Christian Harding, CEO, VaxNewMo

Wouter Hazenbos, Scientist, Genentech

William Heath, Scientific Advisor, Avalia Immunotherapies

Charles Heffernan, Member, BioPhorum Operations Group; Director, C.R.B.

Charles Heffernan | Member, BioPhorum Operations Group; Director | C.R.B. » speaking at Vaccine West Coast

Daniel Henderson, CEO & CSO, Verndari

Dr Robert Hollingsworth, Vice President and Chief Scientific Officer, Cancer Vaccines and Immunotherapeutics, Pfizer

Dr Peter Hotez, Dean, National School Of Tropical Medicine, Director, Texas Children?S Hospital Center, Baylor College of Medicine

Beckie Ingram, Senior Lecturer & Principal Investigator, QUB

Hasan Jafri, Senior Director, Clinical Research And Development, Infectious Disease And Vaccines, MedImmune Inc

Risat Jannat, Director, Global Vaccines & Biologics Commercialization,, Merck

Risat Jannat | Director, Global Vaccines & Biologics Commercialization, | Merck » speaking at Vaccine West Coast

Kathrin Jansen, Senior Vice President And Chief Scientific Officer, Pfizer

Dr Joseph Jardine, Head Of Antibody Discovery, Institute For Protein Innovation

Vanessa Jonsson, Assistant Research Professor, City Of Hope National Medical Center

Dr Maria Karasarides, Executive Director, Immunooncology, Regeneron Pharmaceuticals

Dr Pravin Kaumaya, Professor, Ohio State University

Bruce Keyt, Chief Scientific Officer, IgM. Biosciences Inc

Lakshmi Khandke, Senior Program Advisor, PATH

Kevin Killeen, Chief Scientific Officer, Matrivax

Joseph Kim, Chief Executive Officer, Inovio Pharmaceuticals

Lacey Kitch, Director, Informatics, Parker Institute for Cancer Immunotherapy

Chester Kitchen, Cancer Patient Advocate

Chester Kitchen |  | Cancer Patient Advocate » speaking at Vaccine West Coast

Steven Kleiboeker, Vice-President, Research And Development, Viracor Eurofins

Dr Vadim Klyushnichenko, Vice President Of Pharmaceutical Development And Quality, Calibr, a division of Scripps Research

Alexander Koglin, Founder, NTxBio

Dr Alexander Kort, Senior Vice President Corporate Development, Themis Bioscience

Theresa Lavallee, Head Of Translational Medicine, Parker Institute for Cancer Immunotherapy

Bruce Lee, Professor of Health Policy and Management, City University of New York

Dr Andrew Lees, Scientific Director, Fina BioSolutions

Ofer Levy, Professor Of Pediatrics, Precision Vaccines Program, Boston Children's Hospital Harvard Medical School

Anders Lilja, VP Technical Development, Hookipa Biotech

Jimmy Lin, Chief Scientific Officer, Freenome

Kirsty Maclean, Associate Scientific Director, Biomarker And Translational Strategy, Definiens

Holden T Maecker, Director Immune Monitoring Core, Stanford University

David Maki, General Partner, Altitude Life Science Ventures

David Maki | General Partner | Altitude Life Science Ventures » speaking at Vaccine West Coast

Dr Sumithra Mandrekar, Professor Of Biostatistics And Oncology, Mayo Clinic

Wouter Meuleman, Director, Venture Investments, Illumina Ventures

Francesca Milletti, Associate Director Translational Medicine,, Kite Pharma, a Gilead Company

Michael Mitchell, Professor, University of Pennsylvania

Dr Martin Moore, Chief Executive Officer, Meissa Vaccines, Inc

Justin Moran, Senior Bioprocess Development Director, Pfizer

Pralay Mukhopadhyay, Strategy Lead, Executive Director, Biometrics And Information Sciences, AstraZeneca

Pamela Munster, Professor, University of California San Francisco

Pamela Munster | Professor | University of California San Francisco » speaking at Vaccine West Coast

Michael Murray, Analyst, Biotechnology Value Fund

Duncan Mwangi, Research Director, Zoetis

Stephen Nagler, Executive Director, MedPro Investors Llc

Andreas Niethammer, Senior Vice President, Head of Clin Development, Immunotherapy Solid Tumors, Sorrento Therapeutics Inc

Andreas Niethammer | Senior Vice President, Head of Clin Development, Immunotherapy Solid Tumors | Sorrento Therapeutics Inc » speaking at Vaccine West Coast

Dr Susan Old, Deputy Director Of The Division Of Extramural Activities, NIAID

Dr Susan Old | Deputy Director Of The Division Of Extramural Activities | NIAID » speaking at Vaccine West Coast

Christa Pawlowski, Project Operations Director, SapVax LLC

Sari Pesonen, Vice President Scientific And Clinical Development, Co-Founder, Valo Therapeutics

Tim Phares, Head of Immunology, Explorations in Global Health (ExGloH), Leidos

Clemencia Pinilla, Associate Member, Torrey Pines Institute for Molecular Studies

Jan Poolman, Head Bacterial Vaccine Discovery And Early Development, Janssen

Mary Jo Potter, Founder And Chief Executive Officer, Healthcare Angels

Krishna Prasad, Founder, Citranvi LLC

Brian Price, COO, Blue Water Vaccines, Inc

Bali Pulendran, Department Of Pathology, Microbiology&Immunology, Stanford University School of Medicine

Mary Redman, Associate Member, Clinical Research Division, Fred Hutchinson Cancer Research Center

Mary Redman | Associate Member, Clinical Research Division | Fred Hutchinson Cancer Research Center » speaking at Vaccine West Coast

Tony Reid, Chief Scientific Officer, EpicentRx

John Ross, Vice President, Protein Therapeutics, Cue Biopharma

Dr Raphael Rousseau, Executive Vice President And Head Of Product Development And Chief Medical Officer, Gritstone Oncology

Sarah Royalty Tredo, Director, Emergent Biosolutions

Naik Rumi Armaghan, Director And Head, Sanofi Pasteur

Helen Sabzevari, President, Precigen

Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Infectious Diseases and Vaccines

Bita Sahaf, Technical Director, Stanford CCSU; Correlatives for Parker Institute for Cancer Immunotherapy; Snr Research Scientist, Stanford Cancer Institute

Juan Salazar, Executive Vice President, Connecticut Children's Medical Center

Richard Scheuermann, Director, J Craig Venter Institute

Dr Stephen Schoenberger, Professor, La Jolla Institute for Allergy and Immunology

Dr Mike Schopperle, Chief Executive Officer, CureMeta Llc

Martina Sersch, Chief Medical Officer, Mustang Bio

Dr Alessandro Sette, Center Head, Division Head, And Professor,, La Jolla Infectious Disease Institute

Sujan Shresta, Associate Professor, La Jolla Institute for Immunology

William Smith, Chief Executive Officer, Alliance for Multispecialty Research LLC

Julia Spencer, Associate Vice President, Global Vaccine Public Policy, Partnerships, MSD

Dr Gary Starling, Associate Vice President, Discovery Biologics, Merck

Mike Stebbins, MCDC Executive Director, Advanced Technology International

Angelos Stergiou, President & Chief Executive Officer, Sellas Life Sciences Group

Dr Lesley Stolz, EVP & Chief Business Officer, Annexon Biosciences

Nancy Sullivan, Chief And Biodefense Research Section, Vaccine Research Center, National Institutes of Health

Kena Swanson, Director, Pfizer

Jun Tang, Senior Manager Philanthropic Venture Fund And Clinical Accelerator, Cancer Research Institute

Dr Raymond Tesi, Chief Executive Officer, INmune Bio

Meghna Das Thakur, Biomarker Lead, T Cell Bi-specifics, Genentech

Craig Thompson, Chief Scientific Officer, Blue Water Vaccines, Inc

Michael Tippie, General Manager, Alignment Ventures

Michael Tippie | General Manager | Alignment Ventures » speaking at Vaccine West Coast

Dr Sangeeta Tiwari, Associate (Faculty), Albert Einstein College of Medicine

Dr Steven Townson, Senior Principal Scientist, Early Oncology Development, Merck Research Laboratories

Ovid Trifan, Chief Medical Officer, Senior Vice President Of Clinical Development, Apexigen, Inc

Vu Truong, Chief Executive Officer And Chief Scientific Officer, Aridis Pharmaceuticals

Chia-Wei Tsai, Senior Scientist in Force Health Protection, USAMMDA

Dr Sean Tucker, Chief Scientific Officer And Vice President Research, Vaxart

Louis-Philippe Vezina, Chief Executive Officer, Angany

Kalpit Vora, Director, Merck And Company

Dr I Ming Wang, Director, Pfizer

Wen Bo Wang, Senior Vice President Of Technical Operations, Fate Therapeutics

James Wassil, Business Unit Lead, Vaccines, Patient And Health Impact, Pfizer

Jo Anne Welsch, Scientific Director, Path

Jo Anne Welsch | Scientific Director | Path » speaking at Vaccine West Coast

David Whitacre, Senior Vice President, VLP Biotech

Nancy Whiting, Sr Vice President, Development, Seattle Genetics Inc

Jon Wigginton, Chief Medical Officer And Senior Vice President Of Clinical Development, MacroGenics

Prof Ignasio Wistuba, Professor And Chairman, The University of Texas MD Anderson Cancer Center

Kristen Wong, Associate, Altitude Life Science Ventures

Kristen Wong | Associate | Altitude Life Science Ventures » speaking at Vaccine West Coast

Lauren V Wood MD, Chief Medical Officer, P.D.S. Biotechnology Corp

Larry Zeitlin, President, Mapp Biopharmaceutical, Inc.

Heidi Zhang, Global Head Analytical Development Cell Therapy, Juno Therapeutics GmbH, A Celgene Company (BMS)

Xiaoping Zhu, Interim Associate Dean & Department Chair, University of Maryland, Baltimore

 

DOWNLOAD PROSPECTUS

 

Contact us

To sponsor or exhibit contact:
Oliver Breed
+44 (0)207 092 1156

oliver.breed@terrapinn.com


To speak:
Lauren Sheppard
+44 (0)207 092 1211

lauren.sheppard@terrapinn.com